Our Mission

DeepMed IO is a MedTech company based in the UK. Our mission is to use AI to increase the accuracy and speed of diagnostic processes and deliver personalized care solutions for patients, thus prolonging their survival and improving their quality of life. Our exceptional team of experienced bioinformaticians and machine learning experts work hard around the clock to deliver AI tools with practical use in the clinic.

AI – Augmented Histopathology

Histopathology services are critical for the timely and accurate treatment of cancer patients. The thorough examination of stained tissue sections under the microscope by expert pathologists is time-consuming and in many cases complex. The digitalisation of tissue sections via Whole Slide Imaging infrastructure helps, but a lot of the bottlenecks remain. All around the world, cancer cases increase year-on-year while numbers of expert pathologists lag behind.

DeepMed IO software facilitates and augments expert pathologists by employing artificial intelligent technology to pre-annotate and analyse WSI slides, ready to be validated by the experts. The streamlined workflow is designed around the existing gold standards, with case-specific modules. The deep-learning neural networks are specifically trained for each module, utilising expert-curated training sets and validated by quality-assured datasets.

Members Of

 Supported by